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Purpose: Chemotherapy for lung cancer can have a detrimental effect on white blood cell (WBC) and red blood
cell (RBC) counts. Physical exercise may have a role in improving WBCs and RBCs, although few studies have
examined cancer patients receiving adjuvant therapies. The purpose of this pilot trial was to examine the effects of
an exercise intervention utilizing resistance bands on WBCs and RBCs in lung cancer patients receiving curative
intent chemotherapy.
Methods: A sample of lung cancer patients scheduled for curative intent chemotherapy was randomly assigned to
the exercise intervention (EX) condition or usual care (UC) condition. The EX condition participated in a three times
weekly exercise program using resistance bands for the duration of chemotherapy.
Results: A total of 14 lung cancer patients completed the trial. EX condition participants completed 79% of
planned exercise sessions. The EX condition was able to maintain WBCs over the course of the intervention
compared to declines in the UC condition (p = .008; d = 1.68). There were no significant differences in change
scores in RBCs.
Conclusions: Exercise with resistance bands may help attenuate declines in WBCs in lung cancer patients receiving
curative intent chemotherapy. Larger trials are warranted to validate these findings. Ultimately these findings could
be informative for the development of supportive care strategies for lung cancer patients receiving chemotherapy.
Trial registration: Clinical Trials Registration #: NCT01130714.
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Chemotherapy for lung cancer can have a detrimental ef-
fect on both red blood cell (RBC) and white blood cell
(WBC) counts due to bone marrow suppression. Declines
in WBC subsets can result in delays in chemotherapy and
reductions in dosage (Khan et al. 2008) and increased risk
of infection, mortality and hospital admissions (Klastersky
et al. 2009). Similarly, declines in RBC indices can ex-
acerbate fatigue, reduce quality of life, result in delays in* Correspondence: kristinak@nipissingu.ca
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in any medium, provided the original work is ptreatment, and have a negative impact on survival (Hauser
et al. 2006; Pirker et al. 2003).
Although a large body of research has focused on the
role of physical exercise as a potential supportive care
strategy for cancer survivors (Speck et al. 2010), relatively
little research has examined its effect on hematologic out-
comes, especially in lung cancer patients and survivors.
In general populations exercising is associated with an
increase in circulating WBCs (Freidenreich and Volek
2012). Although WBCs typically return to baseline hours
after an acute bout of exercise in healthy populations, it is
unclear what the effect of regular exercise may be in indi-
viduals being treated for cancer whose levels are compro-
mised as a result of adjuvant therapies. Of the research tos an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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http://www.springerplus.com/content/3/1/15date, significant improvements in WBC subsets have been
found following an exercise program in patients receiving
high dose chemotherapy followed by autologous peripheral
blood stem cell transplantation (Dimeo et al. 1997b) and in
prostate cancer survivors receiving androgen deprivation
therapy (Galvao et al. 2008).
Exercise has also been found to have a positive effect on
RBC indices in human and animal models (Hu et al. 2011).
Although not fully understood, the benefits of exercise on
RBC counts may be at least partially explained through
the intertwining of the processes of ossification and hema-
topoiesis (Hu et al. 2011). Through high force and/or im-
pact exercise, bone formation is stimulated resulting in a
simultaneous rise in RBC indices (Guadalupe-Grau et al.
2009). Although the exact mechanism has yet to be discov-
ered, a recent study found evidence of crosstalk between
osteoblasts and hematopoietic stem cells which may ac-
count for an increase in both RBC indices and biomarkers
of bone formation (Hu et al. 2008; 2011). Only a paucity of
research has examined the effect of an exercise interven-
tion on RBC indices in cancer survivors, including in pa-
tients receiving high dose chemotherapy (Dimeo et al.
1997a), breast cancer survivors receiving radiation therapy
(Drouin et al. 2006) and chemotherapy (Dolan et al. 2010).
Results were generally similar to work in other populations
indicating a favourable effect of exercise on RBCs.
In this paper we add to the small body of existing re-
search examining the effect of exercise on hematologic
outcomes in cancer patients. Moreover, we focus on lung
cancer patients on chemotherapy, a group that has only
recently been studied in the exercise domain (Adamsen
et al. 2012; Hoffman et al. 2013; Kuehr et al. 2013; Quist
et al. 2012; Temel et al. 2009). The purposes of this pilot
trial were to examine the effects of an exercise training
intervention utilizing resistance bands on WBC and RBC
counts in lung cancer survivors receiving curative intent
chemotherapy compared to a usual care control group. It
was hypothesized that lung cancer survivors in the exer-
cise (EX) condition would maintain WBC and RBC counts
during chemotherapy compared to declines in the usual
care (UC) condition.Methods
Trial design
The study was a two-armed parallel design prospective
randomized controlled trial. Study participants were
stratified by sex and type (non-small cell vs. small cell)
and randomly assigned with a computer-generated pro-
gram to either the EX or UC conditions in a 1:1 ratio in
blocks of 4. An outside research assistant created the al-
location sequence and assembled the results into a series
of sequentially numbered opaque envelopes. The results
were concealed from the research team until the nextconsecutive envelope was opened by a research assistant
in the presence of the study participant.
Participants and setting
The study was approved by the University and Medical
Center Institutional Review Board at East Carolina
University. Participants were recruited from a cancer
center in Eastern North Carolina and gave written and
informed consent in English before commencing the
trial (Clinical Trials Registration number NCT01130714).
Eligibility criteria included (a) histologically confirmed
diagnosis of non-small cell or small cell lung cancer, (b)
eligible for chemotherapy with curative intent, (c) 21 years
of age or older, and (d) approved to participate in trial by
treating oncologist. Individuals were excluded if they had
already commenced chemotherapy to treat lung cancer.
All baseline and post intervention assessments were
completed at the cancer center.
Exercise program
Participants randomized to the EX condition participated
in the exercise program for the duration of their chemo-
therapy starting one week after the first cycle of chemother-
apy began until 3 weeks after the last cycle (approximately
4 cycles lasting a total 12 weeks). The exercise program
consisted of an exercise routine with resistance bands that
consisted of total body exercises three times per week with
at least one day of rest between sessions. Exercises simu-
lated traditional resistance exercises with free weights and
included biceps curls, shoulder pull backs, seated rows, tri-
ceps extensions, chest press, leg extensions, hip flexion, hip
abduction, hip adduction, heel raises, and chair squats. Re-
sistance bands are portable, inexpensive, can be used for a
variety of total body exercises, and have been used success-
fully with older populations (Egana et al. 2010) and in a
recent trial of cancer survivors receiving high dose che-
motherapy and hematopoietic stem cell transplantation
(Hacker et al. 2011). One weekly exercise session with the
resistance bands was completed under the supervision of
an exercise trainer at the treating cancer center while the
other two sessions per week were performed at the par-
ticipant’s home with guidance from a guide booklet and
DVD developed for the trial. Exercise sessions were not
completed on days when chemotherapy was administered.
The exercise routine consisted of warm-up exercises and
stretches followed by 12 total body resistance exercises
working major muscle groups for two sets of 15 repetitions.
The full routine took approximately 30 minutes to com-
plete. All exercises were chair based and developed from an
existing program utilized for cardiac and pulmonary pa-
tients by an exercise physiologist. Participants were asked
to maintain sufficient tension in the bands to find it
challenging to complete the second set of repetitions. The
UC condition continued with usual care and received a
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after completion of all post intervention measures.
Primary and outcome measures
Primary outcome measures (i.e., WBC and RBC counts)
were assessed at baseline (within one week of commen-
cing the first cycle of chemotherapy) and post intervention
(three to four weeks following the last delivery of chemo-
therapy). EX condition participants were instructed to not
complete any exercise sessions within 24 hours of their
scheduled post intervention blood draw.
White and red blood cell counts were determined by
routine CBC at the cancer center laboratory. Results
were obtained from patient charts.
Other measures
Demographic and medical information were assessed from
patient records (cancer type, stage, treatment received)
and questionnaire (date of birth, race, height, weight,
smoking status, number of comorbidities).
Exercise level at baseline was determined by the Leisure
Score Index (LSI) of the Godin Leisure-Time Exercise
Questionnaire GLTEQ; (Godin et al. 1986). The LSI as-
sesses the average frequency of light, moderate and vigor-
ous exercise in a typical week in the past month. As in
previous investigations (Vallance et al. 2007), a modified
version was used that also measures duration of exercise.
The LSI has been found to be valid and reliable with
concurrent validity coefficients of .32 compared to an ac-
celerometer and .56 when compared to VO2max and a
one-month test-retest reliability of .62 (Jacobs et al. 1993).
For each intensity level (i.e., light, moderate, vigorous), the
number of sessions per week of exercise was multiplied
by the average number of minutes per session to obtain
weekly measures of exercise minutes at each intensity.
Two separate variables for average minutes of moderate
intensity exercise and average minutes of vigorous in-
tensity exercise were calculated. An additional composite
measure of moderate-to-vigorous exercise minutes in a
typical week in the past month was created by multiplying
the vigorous intensity minutes variable by two and adding
it to the moderate intensity variable [i.e., (weekly vigorous
minutes × 2) + (weekly moderate minutes)] as per the US
Department of Health and Human Services’ (Physical
Activity Guidelines for Americans 2008 physical activity
categories. Study participants were classified as “exer-
cisers” or “non-exercisers” based on whether or not they
were meeting American College of Sports Medicine public
health recommendations for exercise (i.e., 150 weekly mi-
nutes of moderate and vigorous intensity exercise com-
bined or 60 weekly minutes of vigorous intensity exercise;
Haskell et al. 2007) according to the exercise variables de-
scribed above. To remain consistent with public health
recommendations for exercise, light intensity exerciseminutes were not included in the exercise measures
(Haskell et al. 2007).
Adherence to the EX intervention was assessed from
weekly exercise logs. EX condition participants were asked
to record each exercise session in their logs and return
them to the exercise trainer during their weekly super-
vised exercise session.
Sample size calculation and statistical analyses
At 0.67 power, 12 participants were required to detect a
large effect (d = 1.0) at α = .05. Comparisons between base-
line demographic and medical characteristics and baseline
outcome measures were examined by independent sam-
ples t-tests for continuous data and chi-square analyses
for categorical data. Independent samples t-tests were
used to calculate differences between the EX and UC con-
ditions for WBC and RBC at post-intervention. Differ-
ences in change scores between groups were examined
using independent samples t-tests. Effect sizes (d) were
calculated by dividing the difference of the means by the
pooled standard deviation (Cohen 1992). An effect size of
0.2 was considered a small effect, 0.5 a medium effect, and
0.8 and greater a large effect (Cohen 1992). Because of the
small sample size and the difficult to treat population, a
modified intention-to-treat analysis was used for all ana-
lyses. The modification included exclusion of participants
from analyses if they had suffered a major adverse event
during the course of the intervention or did not complete
any scheduled exercise sessions (supervised or home-
based). All other participants were included in the analyses
including those with some missing baseline demographic
data (see Table 1).
Results
Participants were recruited for the study between January
2010 and September 2011 (Figure 1). Of the 29 deemed
eligible, 23 were recruited for the study indicating a 79%
recruitment rate. A total of 61% (14/23) of participants
were included in the analyses. The main reason for exclu-
sion from analyses was failure to reach the participant
again after multiple attempts for contact resulting in in-
completion of all exercise sessions (both supervised and
home-based; n = 5). Significantly more EX condition par-
ticipants were not included in the analyses compared to
the control condition (p = .012). There were no significant
differences in demographic and medical characteristics be-
tween the groups at baseline (Table 1). Although not sta-
tistically different, the UC condition had a higher number
of average weekly exercise minutes at baseline compared
to the EX condition due to two UC participants being
found to be regular exercisers. We re-analyzed the data
with these two participants excluded and found almost
identical findings to the original analyses with the full
sample. Thus we report the analyses with the full data in
Table 1 Baseline demographic and medical characteristics
Variable Overall EX UC P
Age (years; N = 14) 58.8 (12.9) 64.2 (12.9) 55.8 (12.6) .258
Sex (N = 14)
Male 10 4 6 .597
Female 4 1 3
Race (N = 14)
Caucasian 11 4 7 .923
African American 3 1 2
Education (N = 10)
High school or less 7 3 4 .490
Some post secondary school 3 2 1
Body mass index (kg/m2) (N = 14) 31.5 (7.4) 29.7(4.3) 33.4 (9.8) .462
Smoking status (N = 14)
Never smoked 2 1 1 .375
Ex-smoker 8 4 4
Current smoker 2 0 2
Quit during treatment 2 0 2
Exercise at baseline (N = 11)
Exerciser 2 0 2 .114
Non-exerciser 9 5 4
MV exercise minutesa 114.2 (232.1) 8 (11.0) 220.4 (304.9) .158
Moderate exercise minutesb 47.3 (79.1) 8 (11.0) 80 (98.0) .140
Vigorous exercise minutesc 6.4 (18.0) 0 (0) 11.7 (24.0) .310
Number of comorbidities (N = 14) 1.7 (1.1) 2.2 (0.8) 1.2 (1.1) .143
Type of lung cancer (N = 14)
Adenocarcinoma 5 1 4
Squamous 6 4 2
Large cell 1 0 1
Small Cell 1 0 1
NSCLC: Poorly differentiated 1 0 1
Stage (N = 14)
I 1 0 1
IIB 2 1 1
IIIA 8 2 6
IIIB 2 2 0
IV 1 0 1
Chemotherapy (N = 14)
Cisplatin/Irinotecan 7 2 5
Cisplatin/Pemetrexed 2 0 2
Carboplatin/Irinotecan 2 1 1
Paclitaxel/Bevacizum 1 1 0
Carboplatin/Pemetrexed 1 0 1
Taxol/Irinotecan 1 1 0
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Table 1 Baseline demographic and medical characteristics (Continued)
Radiation Therapy (N = 14)
None 1 1 0
50.4 Gy 1 0 1
60 Gy 4 1 3
66 Gy 7 3 4
PCId 1 0 1
Surgery (N = 14)
Inoperable 5 2 3
Preoperative 7 3 4
Postoperative 2 0 2
aModerate-to-vigorous intensity exercise minutes in a typical week in the month before baseline.
bModerate intensity exercise minutes in a typical week in the month before baseline.
cVigorous intensity exercise minutes in a typical week in the month before baseline.
dProphylactic Cranial Irradiation.
Figure 1 Flow diagram Of participants through the trial.
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mean length of the intervention was 12 to 16 weeks. EX
condition participants completed a total of 79% of planned
exercise sessions (both supervised and home-based).
Demographic and medical variables
Details of demographic and medical variables are dis-
played in Table 1. In summary, the average age of the
sample was 59 years, the majority of participants were
male, Caucasian and current or former smokers. All par-
ticipants who received radiation therapy did so concur-
rently with chemotherapy with the exception of one UC
participant who received prophylactic cranial irradiation
following chemotherapy.
Changes in outcome measures
Baseline, post intervention and change scores for RBCs
and WBCs are displayed in Table 2. No significant dif-
ferences were found between groups on either outcome
measure at baseline. At post intervention the EX con-
dition indicated significantly higher WBC scores com-
pared to the UC condition (p = .043; d = 1.19) and no
significant differences in RBC (p = .147; d = .82). Based
on the analysis of differences in change scores, WBC de-
clined significantly less in the EX condition compared
to the UC condition over the course of the intervention
(p = .008) indicating a large effect size (d = 1.68). There
were no significant differences in change scores in RBC
between the EX and UC conditions and the effect size
was small (p = .555; d = .32).
Adverse events
There were three adverse events in the EX condition and
one in the UC condition. In the EX condition one partici-
pant suffered a stroke (completed eight exercise sessions
prior to the stroke), one was hospitalized for most of the
intervention (completed one exercise session prior to
hospitalization) and one withdrew due to increasing weak-
ness and weight loss (completed eight exercise sessions
before withdrawing). In the UC condition one participant
suffered a myocardial infarction during the course of
chemotherapy and was withdrawn from analyses.Table 2 Effects of exercise training on outcome variables
Outcome Baseline
Mean SD P d Mean
WBC (×103/μL)
EX 7.90 1.21 .167 0.93 7.86
UC 9.46 2.16 4.18
RBC (million cells/μL)
EX 4.17 .38 .533 0.40 2.85
UC 4.38 .65 3.27Discussion
This pilot trial provides novel information about the effect
of an exercise program utilizing resistance bands on blood
counts in lung cancer survivors receiving curative intent
chemotherapy. In partial support of our hypotheses, we
found a significant difference in changes in WBC in favor
of the EX condition. There were however no significant
differences in changes in RBC between the EX and UC
conditions.
The positive effect of exercise training on WBC in this
pilot trial is in line with past research that suggested that
participation in an exercise program may improve WBC
and subsets in cancer survivors during adjuvant therapy
(Dimeo et al. 1997b; Fairey et al. 2005; Galvao et al. 2008).
In a randomized study of 70 patients with solid tumours
receiving high dose chemotherapy followed by autologous
peripheral blood stem cell transplantation, (Dimeo et al.
1997b) found that two weeks of daily “biking” with a bed
ergometer significantly reduced duration of neutropenia
compared to a usual care control condition. Moreover,
multiple regression analyses found that the greatest pre-
dictor of neutropenia duration was exercise training when
examined with other variables such as age, body mass
index, total dose of carboplatin, physical performance
at baseline, and number of reinfunded blood stem cells
(Dimeo et al. 1997b). In a subsequent study of a sample of
10 prostate cancer survivors receiving androgen depri-
vation therapy, (Galvao et al. 2008) found a significant in-
crease in lymphocytes from baseline after 10 weeks of
twice weekly resistance training possibly due to improved
immune surveillance in response to resistance training.
Although more research is needed to substantiate these
conclusions, our findings, along with that of past research,
suggest exercise may have a positive effect on WBCs
and subsets in cancer patient populations receiving ad-
juvant therapies.
The failure of our trial to show differences in changes in
RBC counts between the EX and UC conditions was unex-
pected and inconsistent with past research in cancer survi-
vors. For example, in a pilot trial of 16 cancer patients
recently completing high dose chemotherapy, six weeks
of treadmill walking resulted in better improvements inPost Intervention Change
SD P d Mean SD P d
4.40 .043 1.19 -.04 4.67 .008 1.68
1.75 -5.28 1.56
.61 .147 0.82 -1.32 .83 .555 .32
.41 -1.11 .51
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control group (Dimeo et al. 1997a). Similarly, a seven week
long walking program, three to five times per week for a
duration of 20 to 45 minutes, improved RBC counts in a
sample of breast cancer survivors compared to a placebo
stretching group (N = 20; Drouin et al. 2006). One study,
however, indicated no effect of 17 weeks of three times
weekly aerobic or resistance exercise training on haemo-
globin in breast cancer survivors on chemotherapy com-
pared to a control group (N = 242), although significant
positive correlations were found between haemoglobin
and changes in aerobic fitness (Dolan et al. 2010).
The non significant difference in change scores be-
tween groups in RBC counts in our study may be related
to several factors. First, it is possible that an exercise
program utilizing resistance bands is not as effective for
improving RBC outcomes as other forms of exercise. In
both the two trials that resulted in improvements in
RBC indices (Dimeo et al. 1997a; Drouin et al. 2006) the
intervention consisted of a walking program while the
other trial that indicated favourable RBC outcomes re-
lated to exercise involved an aerobic training program
utilizing gym equipment (e.g., treadmills, exercise bikes).
Although resistance training has been found to be effect-
ive in improving RBC indices in general populations (Hu
et al. 2011), it is possible that resistance bands, especially
when utilized by an extremely deconditioned population,
do not cause sufficient force and impact to stimulate
bone formation and subsequent hematopoiesis. More-
over, it is possible that an aerobic training component is
necessary to elicit changes in RBC in cancer populations.
It is also important to note that some exercise trials in
other populations, such as chronic kidney patients (Chen
et al. 2010) and adolescents (Ulrich et al. 2010) did not
result in significant changes in RBCs, and that high vol-
umes of endurance training typically result in decreases
in RBCs (Mairbaurl 2013). Nonetheless, trials with larger
sample sizes, different exercise modalities or means of ob-
jectively measuring exercise intensity may be needed to
determine if exercise can have an effect on RBC counts in
lung cancer populations.
The exercise program used for the study was found to be
safe and possibly feasible for lung cancer patients that initi-
ated the program. Although several adverse events were re-
ported during the course of the intervention none were
believed to be related to the exercise program. This finding
is in line with past research that has found exercise to be
generally safe for cancer survivors, even during treatment
and recovery (Schmitz et al. 2010). Moreover, EX condition
participants were able to complete a relatively high propor-
tion of planned exercise sessions (79%), suggesting a three
times weekly exercise program with resistance bands may
be feasible for this population of lung cancer patients.
Given lung cancer patients frequently indicate low aerobiccapacity and limited mobility, training with resistance
bands may be a more viable mode of exercise compared
to aerobic training (e.g., walking or other cardio pro-
grams). Resistance bands may also be appropriate for lung
cancer populations as all exercises can be completed from
a seated position, tension can be adjusted to accommodate
a wide range of abilities, and the entire program is port-
able enough to be used as an economical home based
exercise program. Future research examining the utility
of resistance bands as a part of exercise programming in
lung cancer and other deconditioned patient popula-
tions is warranted to fully determine its potential use in
supportive care.
The strengths of our trial include the high recruitment
rate (79%), the use of a weekly supervised exercise ses-
sion as part of the protocol, and the relatively high ad-
herence rate to the program (79%) by the EX condition.
The limitations include the small, heterogeneous sample,
differential exclusion from analyses in the EX condition,
and missing data on some baseline variables for some
participants.
Conclusion
In summary, this pilot trial suggests that exercise training
utilizing resistance bands may attenuate declines in WBC
but not RBC counts in lung cancer survivors receiving
curative intent chemotherapy. Moreover, the exercise pro-
gram utilized may be safe and feasible for this population.
Cancer care providers may be advised to consider chair
based exercise programs with resistance bands as a poten-
tial supportive care strategy for lung cancer survivors. Fu-
ture large scale trials are needed to further validate these
results in both lung cancer and other cancer populations.
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